| Style | Citing Format |
|---|---|
| MLA | Booalizadeh P, et al.. "Mecp2 Variant Spectrum and Genotype–Phenotype Correlations in Iranian Rett Syndrome Patients: Identification of a Novel Frameshift Mutation." Journal of Molecular Neuroscience, vol. 76, no. 2, 2026, pp. -. |
| APA | Booalizadeh P, Salahshourifar I, Rabbani B, Rezvani M, Ashrafi M R, Mahdieh N (2026). Mecp2 Variant Spectrum and Genotype–Phenotype Correlations in Iranian Rett Syndrome Patients: Identification of a Novel Frameshift Mutation. Journal of Molecular Neuroscience, 76(2), -. |
| Chicago | Booalizadeh P, Salahshourifar I, Rabbani B, Rezvani M, Ashrafi M R, Mahdieh N. "Mecp2 Variant Spectrum and Genotype–Phenotype Correlations in Iranian Rett Syndrome Patients: Identification of a Novel Frameshift Mutation." Journal of Molecular Neuroscience 76, no. 2 (2026): -. |
| Harvard | Booalizadeh P et al. (2026) 'Mecp2 Variant Spectrum and Genotype–Phenotype Correlations in Iranian Rett Syndrome Patients: Identification of a Novel Frameshift Mutation', Journal of Molecular Neuroscience, 76(2), pp. -. |
| Vancouver | Booalizadeh P, Salahshourifar I, Rabbani B, Rezvani M, Ashrafi M R, Mahdieh N. Mecp2 Variant Spectrum and Genotype–Phenotype Correlations in Iranian Rett Syndrome Patients: Identification of a Novel Frameshift Mutation. Journal of Molecular Neuroscience. 2026;76(2):-. |
| BibTex | @article{ author = {Booalizadeh P and Salahshourifar I and Rabbani B and Rezvani M and Ashrafi M R and Mahdieh N}, title = {Mecp2 Variant Spectrum and Genotype–Phenotype Correlations in Iranian Rett Syndrome Patients: Identification of a Novel Frameshift Mutation}, journal = {Journal of Molecular Neuroscience}, volume = {76}, number = {2}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Booalizadeh P AU - Salahshourifar I AU - Rabbani B AU - Rezvani M AU - Ashrafi M R AU - Mahdieh N TI - Mecp2 Variant Spectrum and Genotype–Phenotype Correlations in Iranian Rett Syndrome Patients: Identification of a Novel Frameshift Mutation JO - Journal of Molecular Neuroscience VL - 76 IS - 2 SP - EP - PY - 2026 ER - |